💨 Abstract

Ajooni Biotech Limited, a vegetarian animal healthcare solutions company, has announced strategic decisions to enhance its financial structure and support future growth. The company is increasing its authorized share capital from Rs40 Crores to Rs50 Crores and issuing convertible warrants worth Rs45 Crores. These warrants will be given to promoters and non-promoters, including Al Maha Investment Fund PCC and Minerva Ventures Fund.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖